Development of recombinant human prolactin receptor antagonists by molecular mimicry of the phosphorylated hormone

Endocrinology

Volumn 139, Issue 2, 1998, Pages 609-616

  Chen, Tian Jian ^a   Kuo, Chiaoyun Benson ^a   Tsai, Kolistin F ^a   Liu, J O Wen ^a   Chen, Dih Yih ^a   Walker, Ameae M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTIC ACID; COMPLEMENTARY DNA; GLUTAMIC ACID; HORMONE RECEPTOR BLOCKING AGENT; MUTANT PROTEIN; PROLACTIN; PROLACTIN RECEPTOR; PROLACTIN RECEPTOR ANTAGONIST; SERINE; UNCLASSIFIED DRUG;

AMINO ACID SUBSTITUTION; ARTICLE; CONTROLLED STUDY; GROWTH REGULATION; PRIORITY JOURNAL; PROLACTIN RELEASE; PROTEIN EXPRESSION; PROTEIN MODIFICATION; PROTEIN PHOSPHORYLATION; SITE DIRECTED MUTAGENESIS;

EID: 0031790107     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.139.2.5758     Document Type: Article

References (42)

1. Wang Y-F, Walker AM 1993 Dephosphorylation of standard prolactin produces a more biologically active molecule. Evidence for antagonism between non-phosphorylated and phosphorylated prolactin in the stimulation of Nb2 cell proliferation. Endocrinology 133:2156-2160
2. Krown KA, Wang Y-F, Ho TWC, Kelly PA, Walker AM 1992 Prolactin isoform 2 as an autocrine growth factor for GH3 cells. Endocrinology 131:595-602
3. Wicks JR, Brooks CL 1995 Biological activity of phosphorylated and dephosphorylated bovine prolactin. Mol Cell Endocrinol 112:223-229
4. Ho TWC, Greenan JR, Walker AM 1989 Mammotroph autoregulation: the differential role of the 24K isoforms of prolactin. Endocrinology 124:1507-1514
5. Ho TWC, Leong FS, Olaso CH, Walker AM 1993 Secretion of specific non-phosphorylated and phosphorylated rat PRL isoforms at different stages of the estrus cycle. Neuroendocrinology 58:160-165
6. Ho TWC, Kawaminami M, Walker AM 1993 Secretion of phosphorylated and non-phosphorylated monomer PRL isoforms during rat pregnancy and pseudopregnancy. Endocr J 1:435-439
7. Wang Y-F, Liu J-W, Mamidi M, Walker AM 1996 Identification of the major site of rat prolactin phosphorylation as serine 177. J Biol Chem 271:2462-2469
8. Luck DN, Gout PW, Beer CT, Smith M 1989 Bioactive recombinant methionyl bovine prolactin: structure-function studies using site-specific mutagenesis. Mol Endocrinol 3:822-831
9. Yotis WW, Sharma VK, Gopalsami C, Chegini S, McNulty J, Hoerman K, Keene Jr J, Simonson LG 1991 Biochemical properties of the outer membrane of Treponema denticola. J Clin Microbiol 29:1397-1406
10. Tanaka T, Shiu RPC, Gout PW, Beer LT, Noble RL, Friesen HG 1980 A new sensitive and specific bioassay for lactogenic hormone: measurement of prolactin and growth hormone in human serum. J Clin Endocrinol Metab 51:1058-1063
11. Cory AH, Owen TC, Barltrop JA, Cory JG 1991 Use of an aqueous soluble tetrazolium/formazan assay for cell growth assays in culture. Cancer Commun 3:207-212
12. Greenan JR, Balden E, Ho TWC, Walker AM 1989 Biosynthesis of the secreted 24K isoforms of prolactin. Endocrinology 125:2041-2048
13. Walker AM 1994 Phosphorylated and nonphosphorylated prolactin isoforms. Trends Endocrinol Metab 5:195-200
14. Sinha YN, Gilligan TA, Lee DW 1984 Detection of high molecular weight variant of prolactin in human plasma by a combination of electrophoretic and immunologic techniques. J Clin Endocrinol Metab 58:752-754
15. Price AE, Lagvinenko KB, Higgins EA, Cole ES, Richards SM 1995 Studies on the microheterogeneity and in vitro activity of glycosylated and non-glycosylated recombinant human prolactin separated using a novel purification process. Endocrinology 136:4827-4833
16. Goffin V, Kinet S, Ferrag F, Binart N, Martial JA, Kelly PA 1996 Antagonistic properties of human prolactin analogs that show paradoxical agonistic activity in the Nb2 bioassay. J Biol Chem 271:16573-16579
17. Luck DN, Gout PW, Kelsay K, Atkinson T, Beer CT, Smith M 1990 Recombinant methionyl bovine prolactin: loss of bioactivity after single amino acid deletions from putative helical regions. Mol Endocrinol 4:1011-1016
18. Luck DN, Huyer M, Gout PW, Beer CT, Smith M 1991 Single amino acid substitutions in recombinant bovine prolactin that markedly reduce its mitogenic ativity in Nb2 cell cultures. Mol Endocrinol 5:1880-1886
19. Goffin V, Norman M, Martial JA 1992 Alanine scanning mutagenesis of human prolactin: importance of the 58-74 region for bioactivity. Mol Endocrinol 6:1381-1392
20. Goffin V, Struman I, Goormaghtigh E, Martial JA 1993 The addition of nine residues at the C-terminus of human prolactin drastically alters its biological properties. Eur J Biochem 214:483-490
21. Goffin V, Struman I, Mainfroid V, Kinet S, Martial JA 1994 Evidence for a second receptor binding site on human prolactin. J Biol Chem 269:32598-32606
22. Goffin V, Martial JA, Summers NL 1995 Use of a model to understand prolactin and growth hormone specificities. Protein Engin 8:1215-1231
23. Fuh G, Colosi P, Wood WI, Wells JA 1993 Mechanism-based design of prolactin receptor antagonists. J Biol Chem 268:5376-5381
24. Schiffer M, Edmundson AB 1967 Use of helical wheels to represent the structures of proteins and to identify segments with helical potential. Biophys J 7:121-135
25. Gertler A, Grosclaude J, Strausburger CJ, Nir S, Djiane J 1996 Real-time kinetic measurements of the interactions between lactogenic hormones and prolactin-receptor extracellular domains from several species support the model of hormone-induced transient receptor dimerization. J Biol Chem 271:24482-24491
26. Davis JA, Linzer DIH 1989 A mutant lactogenic hormone binds, but does not activate, the prolactin receptor. Mol Endocrinol 3:949-953
27. Walker AM, Montgomery DW, Saraiya S, Ho TWC, Garewal HS, Wilson J, Lorand L 1995 Prolactin-immunoglobulin G complexes from human serum act as costimulatory ligands causing proliferation of malignant B lymphocytes. Proc Natl Acad Sci USA USA 92:3278-3282
28. Thorsness PE, Koshland Jr DE 1987 Inactivation of isocitrate dehydrogenase by phosphorylation is mediated by the negative charge of the phosphate. J Biol Chem 262:10422-10425
29. Reizer J, Sutrina SL, Saier MH, Stewart GC, Peterofsky A, Reddy P 1989 Mechanistic and physiological consequences of HPr (ser) phosphorylaton on the activities of the phosphoenyl pyruvate-sugar phosphotransferase system in gram positive bacteria: sugar specific mutants of HPr. EMBO J 8:2111-2120
30. Kaufman RJ, Davis MB, Pathak UK, Hershey JW 1989 The phosphorylation state of eukaryotic initiation factor 2 alters translational efficiency of specific mRNAs. Mol Cell Biol 9:946-958
31. Wittekind M, Reizer J, Deutscher J, Saier MH, Klevit RE 1989 Common structural changes accompany the functional inactivation of HPr by seryl phosphorylation or by serine to aspartate substitution. Biochemistry 28:9908-9912
32. Maciejewski P, Peterson FC, Anderson PJ, Brooks CL 1995 Mutation of serine 90 to glutamic acid mimics phosphorylation of bovine prolactin. J Biol Chem 270:27661-27665
33. Kim BG, Brooks CL 1993 Isolation and characterization of phosphorylated bovine prolactin. Biochem J 296:41-47
34. Ben-Jonathan N, Mershon JL, Allen DL, Steinmetz RW 1996 Extrapituitary prolactin: distribution, regulation, functions, and clinical aspects. Endocr Rev 17:639-669
35. Nagano M, Kelly PA 1994 Tissue distribution and regulation of rat prolactin receptor gene expression. J Biol Chem 269:13337-13345
36. Ginsburg E, Vonderhaar BK 1995 Prolactin synthesis and secretion by human breast cancer cells. Cancer Res 55:2590-2595
37. Clevenger CV, Chang WP, Ngo W, Pasha TL, Montone KT, Tomaszewski JE 1995 Expression of prolactin and prolactin receptor in human breast carcinoma. Evidence for autocrine/paracrine loop. Am J Pathol 146:695-705
38. Mershon J, Sall W, Mitchner N, Ben-Jonathan N 1995 Prolactin is a local growth factor in rat mammary tumors. Endocrinology 136:3619-3623
39. Manni A, Wright C, Davis G, Glenn J, Joehl R, Feil P 1986 Promotion by prolactin of the growth of human breast neoplasms cultured in vitro in the soft agar clinogenic assay. Cancer Res 46:1669-1672
40. Malarkey WB, Kennedy M, Allred LE, Milo G 1983 Physiological concentrations of prolactin can promote the growth of human breast tumor cells in culture. J Clin Endocrinol Metab 56:673-677
41. Mansfield CM 1993 A review of the etiology of breast cancer. J Natl Med Assoc 85:217-221
42. DiMattia GE, Gellersen B, Bohnet HG, Friesen HG 1988 A human lymphoblastoid cell line produces prolactin. Endocrinology 122:2508-2517